ArticleMolecular neurobiology2026
Targeting mGluR1-Mediated Microglial ER Stress Mitigates Copper-Induced TBI Neuroinflammation.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic brain injury (TBI) is continuously accompanied by metal ion imbalance and neuroinflammation. Copper accumulation has been reported to exacerbate secondary brain injury, yet the mechanisms by which copper overload regulates microglial activation remain unclear. Metabotropic glutamate receptor 1 (mGluR1) has been implicated in neuroinflammatory signaling, but its role in copper-mediated TBI pathology has not been fully elucidated. LPS-stimulated BV-2 microglial cells and a controlled cortical impact (CCI) mouse model were adopted to elucidate the role of mGluR1 in copper overload-aggravated TBI. Cell viability, proliferation, apoptosis, microglial polarization, and endoplasmic reticulum stress (ERS) were evaluated using CCK-8, EdU, TUNEL staining, immunofluorescence, qRT-PCR, and Western blot analyses. In vivo, neuronal injury, microglial activation, ERS, and neurological function were assessed by histological staining, molecular assays, and behavioral tests. mGluR1 was silenced using lentiviral shRNA, and ER stress inhibition was verified using 4-phenylbutyric acid (4-PBA). Copper exposure enhanced BV-2 microglial viability and proliferation while suppressing apoptosis under inflammatory conditions. Copper also promoted microglial M1 polarization and activated ER stress signaling through increased CHOP, p-EIF2α, p-PERK, as well as p-IRE1α expression. Silencing mGluR1 significantly reversed these effects, reducing M1 polarization and ER stress activation. In vivo, copper overload aggravated neuronal injury, microglial activation, and neurological deficits in TBI mice. mGluR1 knockdown or pharmacological inhibition of ER stress markedly alleviated neuronal apoptosis, restored microglial polarization balance, reduced ER stress markers, and improved neurological outcomes. Copper overload exacerbates secondary brain injury after TBI and is associated with mGluR1-related neuroinflammatory responses, including microglial M1 polarization and ER stress activation. Targeting the mGluR1-ER stress axis could constitute a promising therapeutic intervention for mitigating neuroinflammation and improving recovery following TBI.
Indexed as
Identifiers
42258122What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.